Regulatory Approval Delays: The successful commercialization of Nano-X's products heavily relies on obtaining necessary regulatory approvals (e.g., FDA, CE Mark) in target markets, and delays or failures in this process could significantly impact their timeline and ability to generate revenue.

Market Adoption Challenges: Despite regulatory clearance, their novel X-ray technology may face resistance from healthcare providers accustomed to traditional systems, making market penetration and widespread adoption a significant hurdle, especially against established competitors.

Manufacturing Scaling Risks: Nano-X's ability to meet market demand depends on its capacity to scale up manufacturing of its proprietary digital X-ray sources and imaging systems, and any issues with production efficiency, quality control, or supply chain could hinder commercial rollout.